394 related articles for article (PubMed ID: 17123618)
1. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients.
Yang P; Ren Y; Li B; Fang W; Meng Q; Kijlstra A
Ophthalmology; 2007 Mar; 114(3):606-14. PubMed ID: 17123618
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Clinical Features and Visual Outcome between Sympathetic Ophthalmia and Vogt-Koyanagi-Harada Disease in Chinese Patients.
Yang P; Liu S; Zhong Z; Du L; Ye Z; Zhou W; Kijlstra A
Ophthalmology; 2019 Sep; 126(9):1297-1305. PubMed ID: 30959067
[TBL] [Abstract][Full Text] [Related]
3. Vitiligo as a First Sign of Vogt-Koyanagi-Harada Disease.
Vukojević M; Vukojevic N; Vuković A; Rupčić B; Blažević M; Blažević A
Acta Dermatovenerol Croat; 2023 Dec; 31(4):229-231. PubMed ID: 38651852
[TBL] [Abstract][Full Text] [Related]
4. Band-shaped keratopathy in Chinese patients with Vogt-Koyanagi-Harada syndrome.
Yang P; Sun M
Cornea; 2011 Dec; 30(12):1336-40. PubMed ID: 21934492
[TBL] [Abstract][Full Text] [Related]
5. The spectrum of Vogt-Koyanagi-Harada disease in Iran.
Hedayatfar A; Hosseini SM; Karimi N; Falavarjani KG; Badie N; Zameni M; Soheilian M
Int Ophthalmol; 2018 Apr; 38(2):443-449. PubMed ID: 28260142
[TBL] [Abstract][Full Text] [Related]
6. [Clinical manifestations and diagnosis of Vogt-Koyanagi-Harada syndrome].
Yang P; Wang H; Zhou H; Huang X; Zhong H; Chen L; Zhong H; Fu T
Zhonghua Yan Ke Za Zhi; 2002 Dec; 38(12):736-9. PubMed ID: 12654224
[TBL] [Abstract][Full Text] [Related]
7. Retinal vessel oxygen saturation is affected in uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; AlBloushi AF; Gikandi PW; Hardarson SH; Stefánsson E
Br J Ophthalmol; 2019 Dec; 103(12):1695-1699. PubMed ID: 30798260
[TBL] [Abstract][Full Text] [Related]
8. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Hemachandran S; Al-Mezaine HS; Kangave D; Al-Muammar AM
Acta Ophthalmol; 2012 Dec; 90(8):e603-8. PubMed ID: 22971163
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids.
Abu El-Asrar AM; Al Tamimi M; Hemachandran S; Al-Mezaine HS; Al-Muammar A; Kangave D
Acta Ophthalmol; 2013 Sep; 91(6):e486-93. PubMed ID: 23575246
[TBL] [Abstract][Full Text] [Related]
10. Acute phase clinical manifestations of patients with Vogt-Koyanagi-Harada disease in Southern China.
Zhang C; Wang Y; Chen Y; Zhou H; Hong Q; Yu X; Ng TK; Cen LP
BMC Ophthalmol; 2023 May; 23(1):199. PubMed ID: 37147563
[TBL] [Abstract][Full Text] [Related]
11. Vogt-Koyanagi-Harada disease presenting as acute angle closure glaucoma at onset.
Yang P; Liu X; Zhou H; Guo W; Zhou C; Kijlstra A
Clin Exp Ophthalmol; 2011; 39(7):639-47. PubMed ID: 22452682
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Dosari M; Hemachandran S; Gikandi PW; Al-Muammar A
Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
[TBL] [Abstract][Full Text] [Related]
13. Predictive factors and adalimumab efficacy in managing chronic recurrence Vogt-Koyanagi-Harada disease.
Feng H; Chen W; Yang J; Kong H; Li H; He Y; Wang H
BMC Ophthalmol; 2024 Jun; 24(1):238. PubMed ID: 38849758
[TBL] [Abstract][Full Text] [Related]
14. Initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease presenting with unilateral exudative retinal detachment despite bilateral choroidal involvement.
AlBloushi AF; Herbort CP; Abu El-Asrar AM
Int Ophthalmol; 2021 Dec; 41(12):4187-4195. PubMed ID: 34346004
[TBL] [Abstract][Full Text] [Related]
15. Clinical and multimodal imaging characteristics of acute Vogt-Koyanagi-Harada disease unassociated with clinically evident exudative retinal detachment.
Attia S; Khochtali S; Kahloun R; Ammous D; Jelliti B; Ben Yahia S; Zaouali S; Khairallah M
Int Ophthalmol; 2016 Feb; 36(1):37-44. PubMed ID: 25939987
[TBL] [Abstract][Full Text] [Related]
16. Vogt-Koyanagi-Harada disease in Hispanic patients.
Sukavatcharin S; Tsai JH; Rao NA
Int Ophthalmol; 2007; 27(2-3):143-8. PubMed ID: 17380271
[TBL] [Abstract][Full Text] [Related]
17. Incidence and clinical features of recurrent Vogt-Koyanagi-Harada disease in Japanese individuals.
Iwahashi C; Okuno K; Hashida N; Nakai K; Ohguro N; Nishida K
Jpn J Ophthalmol; 2015 May; 59(3):157-63. PubMed ID: 25808016
[TBL] [Abstract][Full Text] [Related]
18. Incidence and Risk Factors of Recurrent Anterior Uveitis in Initial Acute-Onset Vogt-Koyanagi-Harada Disease.
Lim YJ; Byon I; Kim HW; Park SW; Kwon HJ; Kim E
Korean J Ophthalmol; 2023 Aug; 37(4):299-306. PubMed ID: 37400085
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease occurred during pregnancy.
Alromaih AZ; Almater AI; Albloushi AF; Alkheraiji NF; Abu El-Asrar AM
Int Ophthalmol; 2023 Jan; 43(1):185-195. PubMed ID: 35945413
[TBL] [Abstract][Full Text] [Related]
20. Incidence, Risk Factors and Surgical Outcomes of Cataract among Patients with Vogt-Koyanagi-Harada Disease.
AlBloushi AF; Alfawaz AM; AlZaid A; Alsalamah AK; Gikandi PW; Abu El-Asrar AM
Ocul Immunol Inflamm; 2021 Jan; 29(1):128-136. PubMed ID: 31638886
[No Abstract] [Full Text] [Related]
[Next] [New Search]
